Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012
- PMID: 28402773
- PMCID: PMC5592722
- DOI: 10.1056/NEJMoa1610187
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012
Abstract
Background: Diagnoses of type 1 and type 2 diabetes in youths present a substantial clinical and public health burden. The prevalence of these diseases increased in the 2001-2009 period, but data on recent incidence trends are lacking.
Methods: We ascertained cases of type 1 and type 2 diabetes mellitus at five study centers in the United States. Denominators (4.9 million youths annually) were obtained from the U.S. Census or health-plan member counts. After the calculation of annual incidence rates for the 2002-2012 period, we analyzed trends using generalized autoregressive moving-average models with 2-year moving averages.
Results: A total of 11,245 youths with type 1 diabetes (0 to 19 years of age) and 2846 with type 2 diabetes (10 to 19 years of age) were identified. Overall unadjusted estimated incidence rates of type 1 diabetes increased by 1.4% annually (from 19.5 cases per 100,000 youths per year in 2002-2003 to 21.7 cases per 100,000 youths per year in 2011-2012, P=0.03). In adjusted pairwise comparisons, the annual rate of increase was greater among Hispanics than among non-Hispanic whites (4.2% vs. 1.2%, P<0.001). Overall unadjusted incidence rates of type 2 diabetes increased by 7.1% annually (from 9.0 cases per 100,000 youths per year in 2002-2003 to 12.5 cases per 100,000 youths per year in 2011-2012, P<0.001 for trend across race or ethnic group, sex, and age subgroups). Adjusted pairwise comparisons showed that the relative annual increase in the incidence of type 2 diabetes among non-Hispanic whites (0.6%) was lower than that among non-Hispanic blacks, Asians or Pacific Islanders, and Native Americans (P<0.05 for all comparisons) and that the annual rate of increase among Hispanics differed significantly from that among Native Americans (3.1% vs. 8.9%, P=0.01). After adjustment for age, sex, and race or ethnic group, the relative annual increase in the incidence of type 1 diabetes was 1.8% (P<0.001) and that of type 2 diabetes was 4.8% (P<0.001).
Conclusions: The incidences of both type 1 and type 2 diabetes among youths increased significantly in the 2002-2012 period, particularly among youths of minority racial and ethnic groups. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the Centers for Disease Control and Prevention.).
Conflict of interest statement
Dr. Marcovina reports receiving consulting fees from Denka-Saiken and MedTest DX. No other potential conflict of interest relevant to this article was reported.
Figures

Comment in
-
Increase in the Incidence of Diabetes and Its Implications.N Engl J Med. 2017 Apr 13;376(15):1473-1474. doi: 10.1056/NEJMe1616575. N Engl J Med. 2017. PMID: 28402766 No abstract available.
-
Diabetes: Rising incidence of diabetes mellitus in youth in the USA.Nat Rev Endocrinol. 2017 Jul;13(7):379-380. doi: 10.1038/nrendo.2017.59. Epub 2017 May 19. Nat Rev Endocrinol. 2017. PMID: 28524169 No abstract available.
-
Mehr und mehr Kinder haben Diabetes.MMW Fortschr Med. 2017 Jun;159(12):37. doi: 10.1007/s15006-017-9842-8. MMW Fortschr Med. 2017. PMID: 28656413 German. No abstract available.
-
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.N Engl J Med. 2017 Jul 20;377(3):301. doi: 10.1056/NEJMc1706291. N Engl J Med. 2017. PMID: 28727405 No abstract available.
References
-
- Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes — the analysis of the data on published incidence trends. Diabetologia. 1999;42:1395–403. - PubMed
-
- Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373:2027–33. - PubMed
Publication types
MeSH terms
Grants and funding
- UL1 TR001111/TR/NCATS NIH HHS/United States
- UC4 DK108173/DK/NIDDK NIH HHS/United States
- U18 DP002710/DP/NCCDPHP CDC HHS/United States
- U18 DP006134/DP/NCCDPHP CDC HHS/United States
- U18 DP006138/DP/NCCDPHP CDC HHS/United States
- U18DP006134/ACL/ACL HHS/United States
- U18DP006138/ACL/ACL HHS/United States
- U18 DP002714/DP/NCCDPHP CDC HHS/United States
- U18DP006133/ACL/ACL HHS/United States
- U01 DP000244/DP/NCCDPHP CDC HHS/United States
- U18DP006131/ACL/ACL HHS/United States
- P30 DK056350/DK/NIDDK NIH HHS/United States
- U18 DP006139/DP/NCCDPHP CDC HHS/United States
- U18 DP002708/DP/NCCDPHP CDC HHS/United States
- U01 DP000247/DP/NCCDPHP CDC HHS/United States
- U18DP006136/ACL/ACL HHS/United States
- U18 DP006131/DP/NCCDPHP CDC HHS/United States
- U01 DP000248/DP/NCCDPHP CDC HHS/United States
- UL1 TR002489/TR/NCATS NIH HHS/United States
- U18 DP006136/DP/NCCDPHP CDC HHS/United States
- U18 DP002709/DP/NCCDPHP CDC HHS/United States
- U18 DP006133/DP/NCCDPHP CDC HHS/United States
- EP-C-15-002/EPA/EPA/United States
- U01 DP000250/DP/NCCDPHP CDC HHS/United States
- U18DP006139/ACL/ACL HHS/United States
- U01 DP000246/DP/NCCDPHP CDC HHS/United States
- U01 DP000254/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical